View Financial HealthIIOT-OXYS 배당 및 자사주 매입배당 기준 점검 0/6IIOT-OXYS 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2026, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2026, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 11/14/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/14/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Mar 22IIOT-OXYS, Inc. announced that it expects to receive $0.21 million in funding from GHS Investments, LLCIIOT-OXYS, Inc. entered into a Securities Purchase Agreement with returning investor GHS Investments, LLC in the amount of up to $210,000 on MArch 21, 2025. The SPA provides for GHS’s purchase, from time to time, of up to 210 shares of the Company’s newly-designated Series D Convertible Preferred Stock (the “ Preferred Stock ”). The initial closing under the SPA consisted of 60 shares of Preferred Stock, stated value $1,200 per share, issued to GHS for an initial purchase price of $60,000, or $1,000 per share. At GHS and the Company’s option, and subject to the terms of the SPA and the Certificate of Designation for the Preferred Stock (the “ COD ”), additional closings in the aggregate amount of up to 150 shares of Preferred Stock for a total aggregate purchase price of up to $150,000 may take place.공시 • Nov 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 11/14/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/14/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 18IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/16/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 02IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 04/01/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Jun 16IIOT-OXYS, Inc. Appoints William D'Agostino to its Advisory BoardIIOT-OXYS, Inc. announced the appointment of William D'Agostino to its Advisory Board as a Technical Sales Consultant for his expertise in Biotechnology and Pharmaceutical Continuous Manufacturing Processes.공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2023, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 01IIOT-OXYS, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2022 , First Quarter and Full Year of 2023IIOT-OXYS, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2022, first quarter and full year of 2023. As predicted, the fourth quarter revenue exceeded that in the third quarter. Overall, 2022 annual revenue exceeded that of 2020 and 2021 combined.This first quarter of 2023 is already on track to exceed the fourth quarter revenue in 2022. Overall, The company expects 2023 revenue to exceed that in 2022.공시 • Dec 06IIOT-OXYS, Inc. announced that it has received $0.061 million in fundingOn December 5, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. J.H. Darbie & Co., Inc. acted as a finder in the transaction. The company has paid $1,220 as finder fee in the transaction.공시 • Nov 25IIOT-OXYS, Inc. Provides Revenue Guidance for the Second Half and Full Year 2022IIOT-OXYS, Inc. provided revenue guidance for the second half and full year 2022. The company expected revenue for the second half of 2022 will exceed that generated in the first half of 2022.In total, the company expected that total revenue for 2022 will be approaching 2019 levels.공시 • Jul 13IIOT-OXYS, Inc. announced that it has received $0.027273 million in fundingOn July 12, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $546 to the finder J.H. Darbie & Co.공시 • Jun 24IIOT-OXYS, Inc. announced that it has received $0.030144 million in fundingOn June 23, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $603 to the finder J.H. Darbie & Co.공시 • Jun 09+ 2 more updatesIIOT-OXYS, Inc. Announces CFO ChangesIIOT-OXYS, Inc. announced that on June 2, 2022, Clifford L. Emmons resigned as Interim Chief Financial Officer and, on the same date, Karen McNemar, age 53, was appointed as the Interim Chief Financial Officer (Principal Financial and Accounting Officer) of the Company. Except as mentioned herein, there are no other arrangements or understandings between Ms. McNemar and any other persons pursuant to which Ms. McNemar was selected in the officer position above. There are no family relationships between Ms. McNemar and any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer. Ms. McNemar has served as Chief Operating Officer since September 20, 2018. From 1998 until August 2017, Ms. McNemar served in many capacities for Medtronic which included as a Senior Director of R&D Operations. Ms. McNemar is a collaborative strategic global business leader with extensive experience in New Product Development and Operations, building strong and effective diverse teams across organizations at all levels. Ms. McNemar is also a trusted advisor, recognized for successful process and program management, with a focus on leading complex initiatives and analyzing data and processes to identify solutions to increase organizational productivity and performance. Ms. McNemar received her Bachelor of Science in Industrial Engineering and Operations Research.공시 • May 24IIOT-OXYS, Inc. announced that it has received $0.043096 million in fundingOn May 23, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $4,310 to the finder J.H. Darbie & Co.공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2022, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 26IIOT-OXYS, Inc. announced that it has received $0.051 million in fundingOn February 24, 2022, IIOT-OXYS, Inc. closed the transaction. The company has received funding from one investor.공시 • Apr 02IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2021, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Mar 18IIOT-OXYS, Inc. Appoints Chandran Seshagiri as Company's Advisory Board ChairmanIIOT-OXYS, Inc. announced the appointment of Chandran Seshagiri as the company's Advisory Board Chairman. Chandran is uniquely qualified to lead company Advisory Board, as he has made significant contributions to company past successful projects and continues to lead company algorithm development efforts on current and future projects. His passion for transforming complex signals into actionable information began with his work at the Harvard-MIT Division of Health Sciences and Technology, where he completed his Ph.D. Chandran's work analyzing physiological time series signals to enable personalized delivery of anesthesia as well as neurostimulation therapy has translated well to the time series data and predictive analyses required for Smart Manufacturing and Structural Health Monitoring applications for IIOT-OXYS, Inc.'s customers.공시 • Sep 28IIOT-OXYS, Inc. (OTCPK:ITOX) entered into a letter of intent to acquire Infinite Automation Systems, Inc.IIOT-OXYS, Inc. (OTCPK:ITOX) entered into a letter of intent to acquire Infinite Automation Systems, Inc. on September 26, 2019. The closing of the transaction is subject to a number of conditions precedent, including satisfactory due diligence and the execution of definitive agreements, including employment agreements with the principal officers and directors of Infinite Automation Systems.공시 • Sep 26IIOT-OXYS, Inc. announced that it expects to receive $0.5 million in funding from Catalytic Capital, LLC and another investorIIOT-OXYS, Inc. (OTCPK:ITOX) announced that it has entered into a securities purchased agreement for the private placement of 12% senior secured convertible notes for gross proceeds of $500,000 on March 6, 2019. The note is convertible, in whole or in part, into common shares at a conversion price of $0.20 per share. The note bears interest at a rate of 12% per annum payable quarterly. The will note matures on March 1, 2021. The notes will be issued in 3 tranches of $100,000 and last tranche of $200,000. The company will issue warrants to purchase one share of the company for 50% of the number of shares of shares issuable upon conversion of the note. Each warrant is immediately exercisable at $0.30 per share and expires five years from the issuance date. The notes will be issued pursuant to exemption provided under Regulation D. On the same date, the company has received $100,000 from Catalytic Capital, LLC and YVSGRAMORAH LLC for $50,000 each in its first tranche. The company also issued 250,000 warrants in the tranche.공시 • Aug 18IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/17/2020, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 30IIOT-OXYS, Inc. announced delayed 10-Q filingOn 06/29/2020, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ITOX 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ITOX 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장IIOT-OXYS 배당 수익률 vs 시장ITOX의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ITOX)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Software)0.9%분석가 예측 (ITOX) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ITOX 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ITOX 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 ITOX 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: ITOX 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 07:20종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스IIOT-OXYS, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2026, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2026, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 11/14/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/14/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2025, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 22IIOT-OXYS, Inc. announced that it expects to receive $0.21 million in funding from GHS Investments, LLCIIOT-OXYS, Inc. entered into a Securities Purchase Agreement with returning investor GHS Investments, LLC in the amount of up to $210,000 on MArch 21, 2025. The SPA provides for GHS’s purchase, from time to time, of up to 210 shares of the Company’s newly-designated Series D Convertible Preferred Stock (the “ Preferred Stock ”). The initial closing under the SPA consisted of 60 shares of Preferred Stock, stated value $1,200 per share, issued to GHS for an initial purchase price of $60,000, or $1,000 per share. At GHS and the Company’s option, and subject to the terms of the SPA and the Certificate of Designation for the Preferred Stock (the “ COD ”), additional closings in the aggregate amount of up to 150 shares of Preferred Stock for a total aggregate purchase price of up to $150,000 may take place.
공시 • Nov 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 11/14/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 15IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/14/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 18IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/16/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 02IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 04/01/2024, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Jun 16IIOT-OXYS, Inc. Appoints William D'Agostino to its Advisory BoardIIOT-OXYS, Inc. announced the appointment of William D'Agostino to its Advisory Board as a Technical Sales Consultant for his expertise in Biotechnology and Pharmaceutical Continuous Manufacturing Processes.
공시 • May 16IIOT-OXYS, Inc. announced delayed 10-Q filingOn 05/15/2023, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 01IIOT-OXYS, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2022 , First Quarter and Full Year of 2023IIOT-OXYS, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2022, first quarter and full year of 2023. As predicted, the fourth quarter revenue exceeded that in the third quarter. Overall, 2022 annual revenue exceeded that of 2020 and 2021 combined.This first quarter of 2023 is already on track to exceed the fourth quarter revenue in 2022. Overall, The company expects 2023 revenue to exceed that in 2022.
공시 • Dec 06IIOT-OXYS, Inc. announced that it has received $0.061 million in fundingOn December 5, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. J.H. Darbie & Co., Inc. acted as a finder in the transaction. The company has paid $1,220 as finder fee in the transaction.
공시 • Nov 25IIOT-OXYS, Inc. Provides Revenue Guidance for the Second Half and Full Year 2022IIOT-OXYS, Inc. provided revenue guidance for the second half and full year 2022. The company expected revenue for the second half of 2022 will exceed that generated in the first half of 2022.In total, the company expected that total revenue for 2022 will be approaching 2019 levels.
공시 • Jul 13IIOT-OXYS, Inc. announced that it has received $0.027273 million in fundingOn July 12, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $546 to the finder J.H. Darbie & Co.
공시 • Jun 24IIOT-OXYS, Inc. announced that it has received $0.030144 million in fundingOn June 23, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $603 to the finder J.H. Darbie & Co.
공시 • Jun 09+ 2 more updatesIIOT-OXYS, Inc. Announces CFO ChangesIIOT-OXYS, Inc. announced that on June 2, 2022, Clifford L. Emmons resigned as Interim Chief Financial Officer and, on the same date, Karen McNemar, age 53, was appointed as the Interim Chief Financial Officer (Principal Financial and Accounting Officer) of the Company. Except as mentioned herein, there are no other arrangements or understandings between Ms. McNemar and any other persons pursuant to which Ms. McNemar was selected in the officer position above. There are no family relationships between Ms. McNemar and any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer. Ms. McNemar has served as Chief Operating Officer since September 20, 2018. From 1998 until August 2017, Ms. McNemar served in many capacities for Medtronic which included as a Senior Director of R&D Operations. Ms. McNemar is a collaborative strategic global business leader with extensive experience in New Product Development and Operations, building strong and effective diverse teams across organizations at all levels. Ms. McNemar is also a trusted advisor, recognized for successful process and program management, with a focus on leading complex initiatives and analyzing data and processes to identify solutions to increase organizational productivity and performance. Ms. McNemar received her Bachelor of Science in Industrial Engineering and Operations Research.
공시 • May 24IIOT-OXYS, Inc. announced that it has received $0.043096 million in fundingOn May 23, 2022, IIOT-OXYS, Inc. closed the transaction. The transaction included participation from a single investor. The company has paid $4,310 to the finder J.H. Darbie & Co.
공시 • Apr 01IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2022, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 26IIOT-OXYS, Inc. announced that it has received $0.051 million in fundingOn February 24, 2022, IIOT-OXYS, Inc. closed the transaction. The company has received funding from one investor.
공시 • Apr 02IIOT-OXYS, Inc. announced delayed annual 10-K filingOn 03/31/2021, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 18IIOT-OXYS, Inc. Appoints Chandran Seshagiri as Company's Advisory Board ChairmanIIOT-OXYS, Inc. announced the appointment of Chandran Seshagiri as the company's Advisory Board Chairman. Chandran is uniquely qualified to lead company Advisory Board, as he has made significant contributions to company past successful projects and continues to lead company algorithm development efforts on current and future projects. His passion for transforming complex signals into actionable information began with his work at the Harvard-MIT Division of Health Sciences and Technology, where he completed his Ph.D. Chandran's work analyzing physiological time series signals to enable personalized delivery of anesthesia as well as neurostimulation therapy has translated well to the time series data and predictive analyses required for Smart Manufacturing and Structural Health Monitoring applications for IIOT-OXYS, Inc.'s customers.
공시 • Sep 28IIOT-OXYS, Inc. (OTCPK:ITOX) entered into a letter of intent to acquire Infinite Automation Systems, Inc.IIOT-OXYS, Inc. (OTCPK:ITOX) entered into a letter of intent to acquire Infinite Automation Systems, Inc. on September 26, 2019. The closing of the transaction is subject to a number of conditions precedent, including satisfactory due diligence and the execution of definitive agreements, including employment agreements with the principal officers and directors of Infinite Automation Systems.
공시 • Sep 26IIOT-OXYS, Inc. announced that it expects to receive $0.5 million in funding from Catalytic Capital, LLC and another investorIIOT-OXYS, Inc. (OTCPK:ITOX) announced that it has entered into a securities purchased agreement for the private placement of 12% senior secured convertible notes for gross proceeds of $500,000 on March 6, 2019. The note is convertible, in whole or in part, into common shares at a conversion price of $0.20 per share. The note bears interest at a rate of 12% per annum payable quarterly. The will note matures on March 1, 2021. The notes will be issued in 3 tranches of $100,000 and last tranche of $200,000. The company will issue warrants to purchase one share of the company for 50% of the number of shares of shares issuable upon conversion of the note. Each warrant is immediately exercisable at $0.30 per share and expires five years from the issuance date. The notes will be issued pursuant to exemption provided under Regulation D. On the same date, the company has received $100,000 from Catalytic Capital, LLC and YVSGRAMORAH LLC for $50,000 each in its first tranche. The company also issued 250,000 warrants in the tranche.
공시 • Aug 18IIOT-OXYS, Inc. announced delayed 10-Q filingOn 08/17/2020, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 30IIOT-OXYS, Inc. announced delayed 10-Q filingOn 06/29/2020, IIOT-OXYS, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.